EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cinobufotalin Ameliorates the Development of Pulmonary Fibrosis by Suppressing the TGF ‐β/Smad Pathway via Regulating PI15

Dong Xia iD, Xingyan Liu, Qiuting Yang, Jie Li, Li Li, Yong You, Jing Wang, Weiyi Fang, Huiling Yang

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Dong Xia und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University, Dongguan, China. Hauptthemen laut MEDLINE: Bufanolides, Pulmonary Fibrosis, Signal Transduction, Smad Proteins. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technology Program of Guangzhou, the Discipline construction project of Guangdong Medical University, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis (PF) is a common hallmark of several types of interstitial lung diseases (ILDs), for which effective therapeutic drugs are lacking. The small‐molecule chemical compound cinobufotalin (CB) has demonstrated significant anti‐cancer effects in lung cancer. In this study, we first found that CB attenuated bleomycin (BLM)‐induced PF and inhibited transforming growth factor‐beta 1 (TGF‐β1)‐induced myofibroblast activation and epithelial‐mesenchymal transition (EMT). Subsequently, comparative RNA sequencing (RNA‐Seq) was conducted to analyse the lung gene expression profiles in mice. Interestingly, peptidase inhibitor 15 (PI15) was identified as a significantly differentially expressed gene (DEG) and may be a potential target in PF progression. Mechanistic studies showed that CB exerts anti‐PF effects by inhibiting PI15 and thereby regulating the TGF‐β/Smad signalling pathway. Our data demonstrated that CB represents a promising anti‐PF drug and may be a candidate therapeutic for PF patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BufanolidesPulmonary FibrosisSignal TransductionSmad ProteinsTransforming Growth Factor betaTransforming Growth Factor beta1AnimalsMiceEpithelial-Mesenchymal TransitionBleomycinHumansMice, Inbred C57BLDisease Models, AnimalMaleMyofibroblasts

Stichwörter der Autor:innen

EMTPI15TGF‐β/Smad pathwaycinobufotalinpulmonary fibrosis

Substanzen

BufanolidesSmad ProteinsBleomycinTransforming Growth Factor betabufalinTransforming Growth Factor beta1

Autor:innen und Institutionen

  • The Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University, Dongguan, China.
  • Department of Respiratory Medicine, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
  • Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Dong Xia

Förderung

  • the Science and Technology Program of Guangzhou
  • the Discipline construction project of Guangdong Medical University
  • the National Natural Science Foundation of China
  • the Open Foundation of NHC Key Laboratory of Tropical Disease Control, Hainan Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Xia, D., Liu, X., Yang, Q., Li, J., Li, L., You, Y., Wang, J., Fang, W., & Yang, H. (2025). Cinobufotalin Ameliorates the Development of Pulmonary Fibrosis by Suppressing the TGF ‐β/Smad Pathway via Regulating PI15. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70788

Vancouver

Xia D, Liu X, Yang Q, Li J, Li L, You Y, et al. Cinobufotalin Ameliorates the Development of Pulmonary Fibrosis by Suppressing the TGF ‐β/Smad Pathway via Regulating PI15. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70788

BibTeX
@article{Xia2025,
  author = {Xia, Dong and Liu, Xingyan and Yang, Qiuting and Li, Jie and Li, Li and You, Yong and Wang, Jing and Fang, Weiyi and Yang, Huiling},
  title = {Cinobufotalin Ameliorates the Development of Pulmonary Fibrosis by Suppressing the TGF ‐β/Smad Pathway via Regulating PI15},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70788}
}
Kostenlos starten →